Vineet Laboratories Limited has appointed Mr. Rajesh Kumar Kathulla as an Executive Director to strengthen its leadership team for a term of five years. The appointment, effective June 11, 2026, is subject to the approval of the company's shareholders. This strategic move aims to leverage Mr. Kathulla's extensive experience in promoter-driven ventures across diverse industries.

The Board of Directors approved the appointment during its meeting held on June 11, 2026. Mr. Kathulla brings over a decade of experience as a Hyderabad-based entrepreneur and corporate director. His professional background includes leading the incorporation and growth of businesses in renewable energy, organic agriculture, lifestyle, and media sectors.

Appointment Details

The company has disclosed the specific details regarding the new appointment and the director's background in a regulatory filing. The table below summarizes the key particulars of the appointment and the director's profile.

Regulatory Disclosures

The company confirmed that Mr. Kathulla is not related to any Director, Key Managerial Personnel (KMP), or Promoters of Vineet Laboratories Limited. Furthermore, the filing states that he is not debarred from holding the office of Director by virtue of any SEBI Order or any other such authority, complying with circulars issued by BSE and NSE.

Mr. Rajesh Kumar Kathulla operates as a promoter-director with a strategic focus on sustainability, innovation, and diversified business development across emerging sectors. The requisite disclosure regarding his appointment has been submitted to the stock exchanges for their information and records.

Vineet Laboratories Limited has deferred its board meeting originally scheduled for July 15, 2026, due to unavoidable circumstances. The meeting was intended to consider and approve the audited financial results for the financial year ended March 31, 2026, a critical disclosure for shareholders assessing the company's annual performance.

The deferment impacts the timeline for the release of the FY26 financial results, which were to be approved pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that a fresh notice specifying the revised date, time, and venue of the board meeting would be intimated to the stock exchanges in due course.

The intimation was addressed to BSE Limited and National Stock Exchange of India Limited, confirming that the regulatory bodies have been notified of the delay. The company’s scrip codes are 543298 on BSE and VINEETLAB on NSE.

Vineet Laboratories Limited has assured that the revised schedule will be communicated in accordance with the requirements of Regulation 29 of the SEBI Listing Regulations. The deferral was signed by Gaddam Venkata Ramana, Managing Director.